HR 1347 — AIMM Act
Congress 119 · introduced 2025-02-13
Latest action: — Referred to the House Committee on Ways and Means.
Sponsors
- Strickland, Marilyn (D, WA-10) — cosponsor
- Hern, Kevin (R, OK-1) — cosponsor
- Feenstra, Randy (R, IA-4) — cosponsor
- Yakym, Rudy (R, IN-2) — cosponsor
Lobbied by (4)
LDA filings that named this bill in their activity descriptions. The lobbying firm (registrant) is paid by the client to lobby on this and related issues.
| Filing | Period | Registrant (lobbying firm) | Client | Income | Matched |
|---|---|---|---|---|---|
| 1st Quarter - Report | 2026 first_quarter | WILLIAMS AND JENSEN, PLLC | STANLEY BLACK & DECKER INC | $60,000 | H.R. 1347 |
| 1st Quarter - Report | 2026 first_quarter | NATIONAL PROPANE GAS ASSOCIATION | NATIONAL PROPANE GAS ASSOCIATION | — | H.R. 1347 |
| 1st Quarter - Report | 2025 first_quarter | THE WASHINGTON TAX & PUBLIC POLICY GROUP | ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION | $450,000 | H.R. 1347 |
| 1st Quarter - Report | 2025 first_quarter | THE WASHINGTON TAX & PUBLIC POLICY GROUP | TAX REFORM COALITION | $400,000 | H.R. 1347 |
Action timeline
- · H11100 — Referred to the House Committee on Ways and Means.
- · Intro-H — Introduced in House
- · 1000 — Introduced in House
Text versions
- Introduced in House · 2025-02-13 — open
Connected on the graph
Inbound (8)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| — | Strickland, Marilyn | cosponsor_of_bill | — | cosponsor | sponsorship |
| — | Hern, Kevin | cosponsor_of_bill | — | cosponsor | sponsorship |
| — | Feenstra, Randy | cosponsor_of_bill | — | cosponsor | sponsorship |
| — | Yakym, Rudy | cosponsor_of_bill | — | cosponsor | sponsorship |
| 2026-01-01 | STANLEY BLACK & DECKER INC | lobbies_on_bill | — | H.R. 1347 | lobbying_bill_mention |
| 2026-01-01 | NATIONAL PROPANE GAS ASSOCIATION | lobbies_on_bill | — | H.R. 1347 | lobbying_bill_mention |
| 2025-01-01 | TAX REFORM COALITION | lobbies_on_bill | — | H.R. 1347 | lobbying_bill_mention |
| 2025-01-01 | ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION | lobbies_on_bill | — | H.R. 1347 | lobbying_bill_mention |
Outbound (1)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2025-01-03 | referred_to_committee | House Ways and Means Committee | — | congress-committee |
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Feenstra, Randy (R, house IA-4) | cosponsor | 2 | — | 3 |
| 2 | Hern, Kevin (R, house OK-1) | cosponsor | 0 | — | 1 |
| 3 | Strickland, Marilyn (D, house WA-10) | cosponsor | 0 | — | 1 |
| 4 | Yakym, Rudy (R, house IN-2) | cosponsor | 0 | — | 1 |
Who's influencing them
Orgs ranked by combined money flow on this bill: LDA filings citing the bill + individual contributions in cycle 2026from donors whose employer matches the org name (Schedule A) to any principal committee in the "who matters" list above.
| # | Org | LDA filings | LDA spend | Donor employees | Employee donations | Total |
|---|---|---|---|---|---|---|
| 1 | ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION | 1 | $450,000 | 0 | $0 | $450,000 |
| 2 | TAX REFORM COALITION | 1 | $400,000 | 0 | $0 | $400,000 |
| 3 | STANLEY BLACK & DECKER INC | 1 | $60,000 | 0 | $0 | $60,000 |
| 4 | retired | 0 | $0 | 387 | $24,552 | $24,552 |
| 5 | incite.org | 0 | $0 | 1 | $3,500 | $3,500 |
| 6 | heritage construction + materials | 0 | $0 | 1 | $3,300 | $3,300 |
| 7 | becu | 0 | $0 | 3 | $2,580 | $2,580 |
| 8 | sound credit union | 0 | $0 | 2 | $2,515 | $2,515 |
| 9 | gowest credit union association | 0 | $0 | 3 | $2,250 | $2,250 |
| 10 | canada life re : for the acli ceo even | 0 | $0 | 1 | $1,250 | $1,250 |
| 11 | canada life reinsurance company | 0 | $0 | 1 | $1,250 | $1,250 |
| 12 | not employed | 0 | $0 | 12 | $930 | $930 |
| 13 | self | 0 | $0 | 18 | $651 | $651 |
| 14 | tapco credit union | 0 | $0 | 1 | $516 | $516 |
| 15 | cor | 0 | $0 | 1 | $387 | $387 |
| 16 | pcma | 0 | $0 | 1 | $275 | $275 |
| 17 | ee overton | 0 | $0 | 1 | $250 | $250 |
| 18 | sound transit | 0 | $0 | 1 | $250 | $250 |
| 19 | hill & co. inc. | 0 | $0 | 1 | $199 | $199 |
| 20 | hartford pathology associates | 0 | $0 | 1 | $153 | $153 |
| 21 | pgi inc | 0 | $0 | 1 | $149 | $149 |
| 22 | chick fil a | 0 | $0 | 1 | $118 | $118 |
| 23 | delta anesthesia | 0 | $0 | 1 | $110 | $110 |
| 24 | centra health | 0 | $0 | 1 | $105 | $105 |
| 25 | bama | 0 | $0 | 1 | $100 | $100 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
4 predicted yes (1%) · 3 predicted no (1%) · 536 unknown (98%)
By party: · R: 3 yes / 0 no / 274 unknown · D: 1 yes / 0 no / 262 unknown · I: 0 yes / 3 no
4 high-confidence positions (voted + sponsor + cosponsor)
- Feenstra, Randy (R · house · IA-4) · cosponsor
- Hern, Kevin (R · house · OK-1) · cosponsor
- Strickland, Marilyn (D · house · WA-10) · cosponsor
- Yakym, Rudy (R · house · IN-2) · cosponsor
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-17 · cosponsored by Yakym, Rudy (cosponsor) · sponsorship
- 2026-05-17 · cosponsored by Hern, Kevin (cosponsor) · sponsorship
- 2026-05-17 · cosponsored by Strickland, Marilyn (cosponsor) · sponsorship
- 2026-05-17 · cosponsored by Feenstra, Randy (cosponsor) · sponsorship
- 2026-01-01 · lobbied on by NATIONAL PROPANE GAS ASSOCIATION (h.r. 1347) · lobbying_bill_mention
- 2026-01-01 · lobbied on by STANLEY BLACK & DECKER INC (h.r. 1347) · lobbying_bill_mention
- 2025-01-03 · was referred to House Ways and Means Committee · congress-committee
- 2025-01-01 · lobbied on by TAX REFORM COALITION (h.r. 1347) · lobbying_bill_mention
- 2025-01-01 · lobbied on by ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION (h.r. 1347) · lobbying_bill_mention